We specialize in company creation and early-stage investment in novel therapeutics, medical devices, diagnostics, and research technologies. We focus on major unmet medical needs that have yet to be addressed by emerging science. Enlisting the world’s leading academic and industry experts, we identify novel technologies (often prior to publication) and create companies that drive those discoveries to commercially and clinically driven milestones. Once those milestones are achieved, we build out the leadership team, create syndicates for later stage financing rounds, and position the technology to make the broadest impact through public financing or acquisition.
 
Life science research is yielding groundbreaking innovations and the pace of discovery is rapidly accelerating. With these innovations come opportunities to significantly improve both length and quality of life, yet scientific discoveries with enormous market potential remain relegated to the academic domain. PureTech’s mission is to uncover the seminal technologies that will power tomorrow’s leading companies. 

 

 

Read more about our team